Persisting SARS‐CoV‐2 viremia after rituximab therapy: Two cases with fatal outcome and a review of literature
Sign Up to like & getrecommendations! Published in 2020 at "British Journal of Haematology"
DOI: 10.1111/bjh.16896
Abstract: SARS‐CoV‐2 infection can cause severe pneumonia (COVID‐19). There is evidence that patients with comorbidities are at higher risk of a severe disease course. The role of immunosuppression in the disease course is not clear. In… read more here.
Keywords: persisting sars; fatal outcome; two cases; rituximab therapy ... See more keywords
SARS-CoV-2 viremia and COVID-19 mortality: A prospective observational study
Sign Up to like & getrecommendations! Published in 2023 at "PLOS ONE"
DOI: 10.1371/journal.pone.0281052
Abstract: Background SARS-CoV-2 viremia has been found to be a potential prognostic factor in patients hospitalized for COVID-19. Objective We aimed to assess the association between SARS-CoV-2 viremia and mortality in COVID-19 hospitalized patients during different… read more here.
Keywords: covid mortality; cov viremia; sars cov;